HEADER ISOMERASE 22-SEP-22 8B58 TITLE CRYSTAL STRUCTURE OF CYCLOPHILIN TGCYP23 FROM TOXOPLASMA GONDII IN TITLE 2 COMPLEX WITH CYCLOSPORIN A COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PPIASE; COMPND 5 EC: 5.2.1.8; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CYCLOSPORIN A; COMPND 9 CHAIN: C, D; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TOXOPLASMA GONDII; SOURCE 3 ORGANISM_TAXID: 5811; SOURCE 4 GENE: TGRH88_026260; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 10 ORGANISM_TAXID: 32630 KEYWDS CYCLOPHILIN, ISOMERASE-IMMUNOSUPPRESSANT COMPLEX, ISOMERASE EXPDTA X-RAY DIFFRACTION AUTHOR E.JIMENEZ-FARACO,J.A.HERMOSO REVDAT 2 22-FEB-23 8B58 1 JRNL REVDAT 1 01-FEB-23 8B58 0 JRNL AUTH F.FAVRETTO,E.JIMENEZ-FARACO,C.CONTER,P.DOMINICI,J.A.HERMOSO, JRNL AUTH 2 A.ASTEGNO JRNL TITL STRUCTURAL BASIS FOR CYCLOSPORIN ISOFORM-SPECIFIC INHIBITION JRNL TITL 2 OF CYCLOPHILINS FROM TOXOPLASMA GONDII . JRNL REF ACS INFECT DIS. V. 9 365 2023 JRNL REFN ESSN 2373-8227 JRNL PMID 36653744 JRNL DOI 10.1021/ACSINFECDIS.2C00566 REMARK 2 REMARK 2 RESOLUTION. 1.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.09 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 154928 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.134 REMARK 3 R VALUE (WORKING SET) : 0.133 REMARK 3 FREE R VALUE : 0.153 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 8309 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.13 REMARK 3 REFLECTION IN BIN (WORKING SET) : 11349 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.96 REMARK 3 BIN R VALUE (WORKING SET) : 0.2280 REMARK 3 BIN FREE R VALUE SET COUNT : 640 REMARK 3 BIN FREE R VALUE : 0.2360 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3256 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 468 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.56000 REMARK 3 B22 (A**2) : -0.67000 REMARK 3 B33 (A**2) : -0.34000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.026 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.027 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.022 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.060 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.981 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.979 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3446 ; 0.010 ; 0.017 REMARK 3 BOND LENGTHS OTHERS (A): 3304 ; 0.001 ; 0.019 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4686 ; 1.571 ; 1.864 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7623 ; 1.170 ; 2.646 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 436 ; 6.337 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 176 ;30.295 ;21.591 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 554 ; 9.964 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 23 ;16.589 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 499 ; 0.105 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3997 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 809 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1735 ; 1.073 ; 1.626 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1734 ; 1.073 ; 1.626 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2179 ; 1.483 ; 2.450 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2180 ; 1.483 ; 2.450 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1711 ; 1.300 ; 1.845 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1712 ; 1.300 ; 1.846 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2498 ; 1.649 ; 2.685 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 3835 ; 2.838 ;20.996 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 3716 ; 2.314 ;20.190 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 6750 ; 1.771 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.30 REMARK 3 ION PROBE RADIUS : 1.00 REMARK 3 SHRINKAGE RADIUS : 1.00 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS REMARK 3 U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 8B58 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-SEP-22. REMARK 100 THE DEPOSITION ID IS D_1292125671. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-MAY-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALBA REMARK 200 BEAMLINE : XALOC REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 154928 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.100 REMARK 200 RESOLUTION RANGE LOW (A) : 45.090 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : 0.04300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.12 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.30 REMARK 200 R MERGE FOR SHELL (I) : 1.13000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO PHASING REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M CITRIC ACID PH 3.5, AND 25% REMARK 280 POLYETHYLENE GLYCOL 3350, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 59.71200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 990 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9180 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1000 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9150 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. REMARK 400 HERE, CYCLOSPORIN A IS REPRESENTED BY THE SEQUENCE (SEQRES) REMARK 400 REMARK 400 THE CYCLOSPORIN A IS CYCLIC PEPTIDE, A MEMBER OF IMMUNOSUPPRESSANT REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: CYCLOSPORIN A REMARK 400 CHAIN: C, D REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION REMARK 400 IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 PRO A 3 REMARK 465 ALA A 4 REMARK 465 PRO A 5 REMARK 465 PRO A 6 REMARK 465 ALA A 7 REMARK 465 ASN A 8 REMARK 465 SER A 9 REMARK 465 GLY A 10 REMARK 465 GLU A 11 REMARK 465 SER A 12 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 PRO B 3 REMARK 465 ALA B 4 REMARK 465 PRO B 5 REMARK 465 PRO B 6 REMARK 465 ALA B 7 REMARK 465 ASN B 8 REMARK 465 SER B 9 REMARK 465 GLY B 10 REMARK 465 GLU B 11 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 104 -76.35 -131.89 REMARK 500 CYS A 163 55.79 -150.56 REMARK 500 PHE B 104 -76.66 -131.97 REMARK 500 CYS B 163 58.51 -153.84 REMARK 500 REMARK 500 REMARK: NULL DBREF1 8B58 A 1 211 UNP A0A7J6KAD1_TOXGO DBREF2 8B58 A A0A7J6KAD1 1 211 DBREF1 8B58 B 1 211 UNP A0A7J6KAD1_TOXGO DBREF2 8B58 B A0A7J6KAD1 1 211 DBREF 8B58 C 1 11 PDB 8B58 8B58 1 11 DBREF 8B58 D 1 11 PDB 8B58 8B58 1 11 SEQRES 1 A 211 MET ALA PRO ALA PRO PRO ALA ASN SER GLY GLU SER SER SEQRES 2 A 211 LEU LEU SER GLU SER GLU LEU PRO ALA GLY ILE SER TYR SEQRES 3 A 211 ALA GLU ALA MET GLU GLY GLY SER ARG PRO LEU LEU HIS SEQRES 4 A 211 PRO ASP ASN PRO VAL VAL PHE PHE ASP ILE SER ILE GLY SEQRES 5 A 211 SER HIS GLU ALA GLY ARG ILE LYS ILE GLU LEU PHE LYS SEQRES 6 A 211 ASN LEU ALA PRO LYS SER ALA GLU ASN PHE ARG GLN PHE SEQRES 7 A 211 CYS THR GLY GLU PHE ARG GLN ASN GLN VAL PRO ILE GLY SEQRES 8 A 211 TYR LYS GLY ALA THR PHE HIS ARG ILE ILE LYS ASN PHE SEQRES 9 A 211 MET ILE GLN GLY GLY ASP PHE VAL LYS GLY ASP GLY THR SEQRES 10 A 211 GLY ARG LEU SER ILE TYR GLY SER SER PHE PRO ASP GLU SEQRES 11 A 211 ALA PHE VAL LEU PRO HIS PHE ARG SER GLY LEU LEU SER SEQRES 12 A 211 LEU ALA ASN SER GLY PRO ASP THR ASN GLY CYS GLN PHE SEQRES 13 A 211 PHE ILE THR CYS ALA LYS CYS ASP TRP LEU ASN ARG LYS SEQRES 14 A 211 HIS VAL VAL PHE GLY GLN VAL LEU GLY LYS GLU SER MET SEQRES 15 A 211 GLN VAL VAL ARG LYS ILE GLU HIS VAL THR VAL ASP GLY SEQRES 16 A 211 GLY ASN ARG PRO ARG ILE PRO VAL THR VAL THR GLN CYS SEQRES 17 A 211 GLY GLU LEU SEQRES 1 B 211 MET ALA PRO ALA PRO PRO ALA ASN SER GLY GLU SER SER SEQRES 2 B 211 LEU LEU SER GLU SER GLU LEU PRO ALA GLY ILE SER TYR SEQRES 3 B 211 ALA GLU ALA MET GLU GLY GLY SER ARG PRO LEU LEU HIS SEQRES 4 B 211 PRO ASP ASN PRO VAL VAL PHE PHE ASP ILE SER ILE GLY SEQRES 5 B 211 SER HIS GLU ALA GLY ARG ILE LYS ILE GLU LEU PHE LYS SEQRES 6 B 211 ASN LEU ALA PRO LYS SER ALA GLU ASN PHE ARG GLN PHE SEQRES 7 B 211 CYS THR GLY GLU PHE ARG GLN ASN GLN VAL PRO ILE GLY SEQRES 8 B 211 TYR LYS GLY ALA THR PHE HIS ARG ILE ILE LYS ASN PHE SEQRES 9 B 211 MET ILE GLN GLY GLY ASP PHE VAL LYS GLY ASP GLY THR SEQRES 10 B 211 GLY ARG LEU SER ILE TYR GLY SER SER PHE PRO ASP GLU SEQRES 11 B 211 ALA PHE VAL LEU PRO HIS PHE ARG SER GLY LEU LEU SER SEQRES 12 B 211 LEU ALA ASN SER GLY PRO ASP THR ASN GLY CYS GLN PHE SEQRES 13 B 211 PHE ILE THR CYS ALA LYS CYS ASP TRP LEU ASN ARG LYS SEQRES 14 B 211 HIS VAL VAL PHE GLY GLN VAL LEU GLY LYS GLU SER MET SEQRES 15 B 211 GLN VAL VAL ARG LYS ILE GLU HIS VAL THR VAL ASP GLY SEQRES 16 B 211 GLY ASN ARG PRO ARG ILE PRO VAL THR VAL THR GLN CYS SEQRES 17 B 211 GLY GLU LEU SEQRES 1 C 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA SEQRES 1 D 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA HET DAL C 1 5 HET MLE C 2 9 HET MLE C 3 9 HET MVA C 4 8 HET BMT C 5 13 HET ABA C 6 6 HET SAR C 7 5 HET MLE C 8 9 HET MLE C 10 9 HET DAL D 1 5 HET MLE D 2 9 HET MLE D 3 9 HET MVA D 4 8 HET BMT D 5 13 HET ABA D 6 6 HET SAR D 7 5 HET MLE D 8 9 HET MLE D 10 9 HETNAM DAL D-ALANINE HETNAM MLE N-METHYLLEUCINE HETNAM MVA N-METHYLVALINE HETNAM BMT 4-METHYL-4-[(E)-2-BUTENYL]-4,N-METHYL-THREONINE HETNAM ABA ALPHA-AMINOBUTYRIC ACID HETNAM SAR SARCOSINE FORMUL 3 DAL 2(C3 H7 N O2) FORMUL 3 MLE 8(C7 H15 N O2) FORMUL 3 MVA 2(C6 H13 N O2) FORMUL 3 BMT 2(C10 H19 N O3) FORMUL 3 ABA 2(C4 H9 N O2) FORMUL 3 SAR 2(C3 H7 N O2) FORMUL 5 HOH *468(H2 O) HELIX 1 AA1 SER A 16 LEU A 20 5 5 HELIX 2 AA2 SER A 25 GLU A 31 1 7 HELIX 3 AA3 ALA A 68 GLY A 81 1 14 HELIX 4 AA4 CYS A 163 ASN A 167 5 5 HELIX 5 AA5 GLY A 178 HIS A 190 1 13 HELIX 6 AA6 SER B 16 LEU B 20 5 5 HELIX 7 AA7 SER B 25 GLU B 31 1 7 HELIX 8 AA8 ALA B 68 GLY B 81 1 14 HELIX 9 AA9 CYS B 163 ASN B 167 5 5 HELIX 10 AB1 GLY B 178 HIS B 190 1 13 SHEET 1 AA1 8 PHE A 97 ILE A 101 0 SHEET 2 AA1 8 MET A 105 GLY A 108 -1 O GLN A 107 N ARG A 99 SHEET 3 AA1 8 PHE A 156 THR A 159 -1 O ILE A 158 N ILE A 106 SHEET 4 AA1 8 LEU A 141 LEU A 144 -1 N LEU A 141 O THR A 159 SHEET 5 AA1 8 VAL A 172 LEU A 177 -1 O GLY A 174 N LEU A 142 SHEET 6 AA1 8 HIS A 54 LEU A 63 -1 N GLU A 62 O GLN A 175 SHEET 7 AA1 8 VAL A 44 ILE A 51 -1 N ILE A 49 O ALA A 56 SHEET 8 AA1 8 VAL A 203 GLU A 210 -1 O GLN A 207 N ASP A 48 SHEET 1 AA2 2 ARG A 84 GLN A 85 0 SHEET 2 AA2 2 VAL A 88 PRO A 89 -1 O VAL A 88 N GLN A 85 SHEET 1 AA3 8 PHE B 97 ILE B 101 0 SHEET 2 AA3 8 MET B 105 GLY B 108 -1 O GLN B 107 N ARG B 99 SHEET 3 AA3 8 PHE B 156 THR B 159 -1 O ILE B 158 N ILE B 106 SHEET 4 AA3 8 LEU B 141 LEU B 144 -1 N LEU B 141 O THR B 159 SHEET 5 AA3 8 VAL B 172 LEU B 177 -1 O GLY B 174 N LEU B 142 SHEET 6 AA3 8 HIS B 54 LEU B 63 -1 N GLU B 62 O GLN B 175 SHEET 7 AA3 8 VAL B 44 ILE B 51 -1 N ILE B 49 O ALA B 56 SHEET 8 AA3 8 VAL B 203 GLU B 210 -1 O GLN B 207 N ASP B 48 SHEET 1 AA4 2 ARG B 84 GLN B 85 0 SHEET 2 AA4 2 VAL B 88 PRO B 89 -1 O VAL B 88 N GLN B 85 LINK C DAL C 1 N MLE C 2 1555 1555 1.34 LINK N DAL C 1 C ALA C 11 1555 1555 1.42 LINK C MLE C 2 N MLE C 3 1555 1555 1.35 LINK C MLE C 3 N MVA C 4 1555 1555 1.34 LINK C MVA C 4 N BMT C 5 1555 1555 1.34 LINK C BMT C 5 N ABA C 6 1555 1555 1.33 LINK C ABA C 6 N SAR C 7 1555 1555 1.34 LINK C SAR C 7 N MLE C 8 1555 1555 1.29 LINK C MLE C 8 N VAL C 9 1555 1555 1.33 LINK C VAL C 9 N MLE C 10 1555 1555 1.33 LINK C MLE C 10 N ALA C 11 1555 1555 1.32 LINK C DAL D 1 N MLE D 2 1555 1555 1.34 LINK N DAL D 1 C ALA D 11 1555 1555 1.41 LINK C MLE D 2 N MLE D 3 1555 1555 1.36 LINK C MLE D 3 N MVA D 4 1555 1555 1.35 LINK C MVA D 4 N BMT D 5 1555 1555 1.35 LINK C BMT D 5 N ABA D 6 1555 1555 1.31 LINK C ABA D 6 N SAR D 7 1555 1555 1.33 LINK C SAR D 7 N MLE D 8 1555 1555 1.33 LINK C MLE D 8 N VAL D 9 1555 1555 1.33 LINK C VAL D 9 N MLE D 10 1555 1555 1.33 LINK C MLE D 10 N ALA D 11 1555 1555 1.33 CRYST1 38.400 119.424 46.350 90.00 103.62 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026042 0.000000 0.006311 0.00000 SCALE2 0.000000 0.008374 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022200 0.00000